Guides for medical practitioners

Legislative requirements for handling drugs, including the prescribing and supply of drugs of addiction and restricted substances

Other guides

New South Wales Opioid Treatment Program: Clinical Guidelines for Methadone and Buprenorphine Treatment of Opioid Dependence

Please note the following regulatory guidelines have been rescinded:

Criteria for the Management of Medication for Attention Deficit Hyperactivity Disorder in Children and Adolescents (TG181).
Criteria for the Management of Medication for Attention Deficit Hyperactivity Disorder in Adults (TG190).

Refer to Prescribe a psychostimulant medication for more information.

Current as at: Friday 10 November 2023

Contact page owner: Pharmaceutical Services